BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22550417)

  • 1. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.
    Uhmann A; Niemann H; Lammering B; Henkel C; Heß I; Rosenberger A; Dullin C; Schraepler A; Schulz-Schaeffer W; Hahn H
    Sarcoma; 2012; 2012():357040. PubMed ID: 22550417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
    Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
    Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
    Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
    Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
    Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
    Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Response of
    Geyer N; Ridzewski R; Bauer J; Kuzyakova M; Dittmann K; Dullin C; Rosenberger A; Schildhaus HU; Uhmann A; Fulda S; Hahn H
    Front Oncol; 2018; 8():396. PubMed ID: 30319965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
    Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
    Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
    Bauer J; Cuvelier N; Ragab N; Simon-Keller K; Nitzki F; Geyer N; Botermann DS; Elmer DP; Rosenberger A; Rando TA; Biressi S; Fagin JA; Saur D; Dullin C; Schildhaus HU; Schulz-Schaeffer W; Aberger F; Uhmann A; Hahn H
    Oncogene; 2021 Aug; 40(31):4955-4966. PubMed ID: 34172934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
    Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
    Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
    Albert B; Hahn H
    Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
    Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
    Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.
    Tostar U; Toftgård R; Zaphiropoulos PG; Shimokawa T
    Genes Cancer; 2010 Sep; 1(9):941-51. PubMed ID: 21779473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma.
    Satheesha S; Manzella G; Bovay A; Casanova EA; Bode PK; Belle R; Feuchtgruber S; Jaaks P; Dogan N; Koscielniak E; Schäfer BW
    Oncogene; 2016 Apr; 35(16):2020-30. PubMed ID: 26189795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines.
    Ridzewski R; Rettberg D; Dittmann K; Cuvelier N; Fulda S; Hahn H
    Front Oncol; 2015; 5():130. PubMed ID: 26106586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice.
    Teichert AE; Elalieh H; Elias PM; Welsh J; Bikle DD
    J Invest Dermatol; 2011 Nov; 131(11):2289-97. PubMed ID: 21814234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog and Vitamin D Signaling Pathways in Development and Disease.
    Hadden MK
    Vitam Horm; 2016; 100():231-53. PubMed ID: 26827954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Functional and Putative Physiological Role of Calcitriol in Patched1/Smoothened Interaction.
    Linder B; Weber S; Dittmann K; Adamski J; Hahn H; Uhmann A
    J Biol Chem; 2015 Aug; 290(32):19614-28. PubMed ID: 26126827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies.
    Oue T; Yoneda A; Uehara S; Yamanaka H; Fukuzawa M
    J Pediatr Surg; 2010 Feb; 45(2):387-92. PubMed ID: 20152358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
    Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM
    Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.